LAWRENCE NOBUHARA: Open Payments
NPI 1740399385 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 100 payments from 20 companies in 2025. Trend: 2023 $1,600 · 2024 $1,160 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $374 |
| PFIZER INC. | 18 | $181 |
| Lilly USA, LLC | 19 | $166 |
| GlaxoSmithKline, LLC. | 6 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Amgen Inc. | 5 | $74 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| Novo Nordisk Inc | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
Products named: VRAYLAR, MOUNJARO, QULIPTA, Kerendia, JARDIANCE, UBRELVY, SHINGRIX, VOQUEZNA.
Industry payments across UT — which companies pay providers there.
